7d76a60b-1e20-41e0-a2b6-ac772acd3dfd
Oxidized low-density lipoproteins as a novel risk factor and therapeutic target for ACMA Human Organoid Model of Aggressive Hepatoblastoma for Disease Modeling and Drug TestingSIRT1 inhibitors mitigate radiation-induced GI syndrome by enhancing intestinal-stem-cell survivalIntronic SMCHD1 variants in FSHDHuman extrahepatic and intrahepatic cholangiocyte organoids show region-specific differentiation potential and model cystic fibrosis-related bile duct diseaseGenome-Wide Analysis Identifies an Essential Human TBX3 Pacemaker EnhancerStem cell reprogrammingPharmaco-proteogenomic characterization of liver cancer organoids for precision oncologyTranscriptomic and Epigenomic Profiling of Histone Deacetylase Inhibitor Treatment Reveals Distinct Gene Regulation Profiles Leading to Impaired Neutrophil DevelopmentCRISPR Craze to Transform Cardiac BiologyPatient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal CancerCRISPR base editing lowers cholesterol in monkeysPatient-Derived Organoids from Colorectal Cancer with Paired Liver Metastasis Reveal Tumor Heterogeneity and Predict Response to ChemotherapyDefining the pathways of heart regenerationA new perspective on fungal metabolitesPatient-derived tumor organoids predict responses to irinotecan-based neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancerIdentification and Characterization of a Transcribed Distal Enhancer Involved in Cardiac Kcnh2 RegulationEmbryonic Microglia Derive from Primitive Macrophages and Are Replaced by cmyb-Dependent Definitive Microglia in ZebrafishT-box transcription factor 3 governs a transcriptional program for the function of the mouse atrioventricular conduction systemThermal Proteome Profiling in Zebrafish Reveals Effects of Napabucasin on Retinoic Acid Metabolism
externalOrganisations
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